StartUp Health January 14, 2025
This largest DxA investment to date supports development of Alamar’s ARGO™ DX System and future in vitro diagnostic tests to advance precision medicine in Alzheimer’s disease.
Alamar Biosciences, a Fremont, CA-based member of the StartUp Health Alzheimer’s Moonshot Community, received $10M from Alzheimer’s Drug Discovery Foundation (ADDF)’s Diagnostics Accelerator (DxA). This investment, the largest in DxA history, will expedite the translation of the ARGO-HT research platform into an FDA-cleared system to support the development of in vitro diagnostic (IVD) tests – the gold standard of diagnostics. source>
Other global health innovation funding reported this week included:
Innovaccer, a San Francisco, CA-based company using AI to activate the flow of healthcare data, raised $275M from B Capital Group, Banner Health, Danaher...
Today's Sponsors
Today's Sponsor